Literature DB >> 31741932

Epithelial Myoepithelial Carcinoma of Parotid Gland.

Pritee Chaudhari1, Jaspreet Kaur1, Aasma Nalwa2, Vaishali Suri2, Ananya Panda3, Suman Bhasker1, Subhash Chander1.   

Abstract

Epithelial myoepithelial carcinoma (EMC) is a rare biphasic tumor of salivary glands with low malignant potential. Although known to occur in submandibular gland and minor salivary glands, its most common location is parotid. Clinical and radiological findings often mimic a benign tumor. Because of rarity of EMC a standard treatment guideline is not yet known. Surgical resection is the most widely used approach. Although it is a low grade tumor, local recurrence rates of 23-50 % have been reported with 25 % chance of distant metastasis. Patients with histo-pathologic markers of aggressive disease should be considered for adjuvant radiotherapy. We report a case of epithelial myoepithelial carcinoma of parotid in a 40 year male that was treated with surgery followed by post-operative radiotherapy. © Association of Otolaryngologists of India 2016.

Entities:  

Keywords:  Epithelial myoepithelial carcinoma; Parotid gland; Radiotherapy; Surgery

Year:  2016        PMID: 31741932      PMCID: PMC6848550          DOI: 10.1007/s12070-016-1025-x

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  16 in total

1.  Epithelial-myoepithelial carcinoma with high grade transformation.

Authors:  Paromita Roy; Martin J Bullock; Bayardo Perez-Ordoñez; Irving Dardick; Ilan Weinreb
Journal:  Am J Surg Pathol       Date:  2010-09       Impact factor: 6.394

2.  Epithelial-myoepithelial carcinoma of the parotid gland: Clinicopathological aspect, diagnosis and surgical consideration.

Authors:  Massimo Politi; Massimo Robiony; Claudio Avellini; Maria Orsaria
Journal:  Ann Maxillofac Surg       Date:  2014-01

Review 3.  Epithelial-myoepithelial carcinoma of the salivary glands: a review of literature.

Authors:  V Tralongo; E Daniele
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

4.  Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract.

Authors:  Raja R Seethala; E Leon Barnes; Jennifer L Hunt
Journal:  Am J Surg Pathol       Date:  2007-01       Impact factor: 6.394

5.  Epithelial-myoepithelial carcinoma of salivary glands.

Authors:  R H Simpson; T J Clarke; P T Sarsfield; P G Gluckman
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

6.  Epithelial myoepithelial carcinoma of head and neck region.

Authors:  Sowrabh Kumar Arora; Nishi Sharma; Minakshi Bhardwaj
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-20

7.  Epithelial-myoepithelial carcinoma of salivary glands.

Authors:  J G Batsakis; A K el-Naggar; M A Luna
Journal:  Ann Otol Rhinol Laryngol       Date:  1992-06       Impact factor: 1.547

8.  A case of epithelial-myoepithelial carcinoma of the parotid gland.

Authors:  Abdullah Taş; Recep Yağiz; Semsi Altaner; Muhsin Koten; Ahmet Rifat Karasalihoğlu
Journal:  Kulak Burun Bogaz Ihtis Derg       Date:  2003-04

9.  Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene.

Authors:  K J Cho; A K el-Naggar; N G Ordonez; M A Luna; J Austin; J G Batsakis
Journal:  Am J Clin Pathol       Date:  1995-04       Impact factor: 2.493

10.  An unusual case of epithelial-myoepithelial carcinoma of the parotid gland radiologically simulating a benign lesion.

Authors:  Shubhra Sharma; Sangeeta Patankar
Journal:  J Oral Maxillofac Pathol       Date:  2014-01
View more
  1 in total

1.  MRI findings of epithelial-myoepithelial carcinoma of the parotid gland with radiologic-pathologic correlation.

Authors:  Taketo Suto; Hiroki Kato; Masaya Kawaguchi; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Tomohiro Ando; Yoshifumi Noda; Fuminori Hyodo; Masayuki Matsuo; Hiromasa Ishihara; Takenori Ogawa
Journal:  Jpn J Radiol       Date:  2022-01-04       Impact factor: 2.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.